-
Subject Areas on Research
-
A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
-
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
-
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).
-
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
-
An Odyssey of complications from band, to sleeve, to bypass; definitive laparoscopic completion gastrectomy with distal esophagectomy and esophagojejunostomy for persistent leak.
-
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers.
-
CT of fundoplication.
-
Caustic ingestion.
-
Celecoxib (celebrex) increases canine lower esophageal sphincter pressure.
-
Changing trends in the proportions of small (≤ 2 cm) proximal and non-proximal gastric carcinomas treated at a high-volume tertiary medical center in China.
-
Cholecystokinin is not a major hormonal regulator of lower esophageal sphincter pressure.
-
Computed tomography for staging esophageal and gastroesophageal cancer: reevaluation.
-
Computed tomography of the gastroesophageal junction: value of the left lateral decubitus view.
-
Elevated intrabolus pressure identifies obstructive processes when integrated relaxation pressure is normal on esophageal high-resolution manometry.
-
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
-
Esophageal and esophagogastric junction cancers, version 1.2015.
-
Esophageal and esophagogastric junction cancers.
-
Esophagogastric junction contractile integral (EGJ-CI) quantifies changes in EGJ barrier function with surgical intervention.
-
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
-
Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.
-
Flow cytometry as a predictive indicator in patients with operable gastric cancer.
-
Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial.
-
Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.
-
Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers.
-
Interrogation of esophagogastric junction barrier function using the esophagogastric junction contractile integral: an observational cohort study.
-
Laparoscopic approaches to symptomatic gastroesophageal reflux.
-
Management of Functional Esophagogastric Junction Outflow Obstruction: A Systematic Review.
-
Pathogenesis and Cells of Origin of Barrett's Esophagus.
-
Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma.
-
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.
-
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.
-
Predictors of Abnormal Functional Luminal Impedance Planimetry Findings in Non-mechanical Esophagogastric Junction Outflow Obstruction.
-
Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered?
-
Principles and techniques of radiation therapy for esophageal and gastroesophageal junction cancers.
-
Reply to Moris et al.
-
Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease.
-
Short-term outcomes after esophagectomy at 164 American College of Surgeons National Surgical Quality Improvement Program hospitals: effect of operative approach and hospital-level variation.
-
Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy.
-
Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.
-
Technical considerations in radiation therapy for gastroesophageal junction cancer.
-
The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction.
-
The Use of Fluorescence Angiography During Laparoscopic Sleeve Gastrectomy.
-
The Utility of Esophageal Motility Testing in Gastroesophageal Reflux Disease (GERD).
-
The endoscopic radiofrequency approach to management of GERD.
-
Three year's experience with the Stretta procedure: did it really make a difference?
-
Keywords of People